![Erwin Sablon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Erwin Sablon
Technik-/Wissenschafts-/F&E-Leiter bei Biocartis SA
Aktive Positionen von Erwin Sablon
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Biocartis SA
![]() Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Technik-/Wissenschafts-/F&E-Leiter | 19.11.2013 | - |
Corporate Officer/Principal | 01.06.2010 | 19.11.2013 |
Karriereverlauf von Erwin Sablon
Ehemalige bekannte Positionen von Erwin Sablon
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIOCARTIS GROUP NV | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2012 | - |
Corporate Officer/Principal | 01.06.2012 | 01.11.2020 | |
ABLYNX | Corporate Officer/Principal | 01.01.2010 | 01.01.2010 |
Fujirebio Europe NV
![]() Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Erwin Sablon
Ghent University | Doctorate Degree |
Vlerick Leuven Gent Management School | Masters Business Admin |
Statistik
International
Belgien | 6 |
Schweiz | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 3 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BIOCARTIS GROUP NV | Health Technology |
Private Unternehmen | 3 |
---|---|
Biocartis SA
![]() Biocartis SA Medical SpecialtiesHealth Technology Biocartis SA develops molecular diagnostic solutions. It focuses on Oncology. The firm’s products include Idylla and Oncology assays and mutation tests. It also provides instant access to personalized medicine for patients. The company was founded by Rudi Pauwels in 2007 and is headquartered in Lausanne, Switzerland. | Health Technology |
Ablynx NV
![]() Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
Fujirebio Europe NV
![]() Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Health Technology |
- Börse
- Insiders
- Erwin Sablon
- Erfahrung